Anlon Healthcare Limited, founded as Anlon Ventures, is a pharma company engaged in the manufacturing of APIs and Pharma Intermediates. It operates out of Rajkot, Gujarat, India.

Anlon achieved a year-on-year revenue growth of 116% in Q2 FY'26, with total income reaching INR 52.32 crore, highlighting its impressive market performance and operational leverage.

The company plans to expand its production capacity to 1,100 metric tons annually to support a targeted 30% revenue CAGR over the next three years. This underscores a strategic focus on growth through capacity and market expansion.

With a confirmed order book of INR 380 crore, including 60% from exports, Anlon demonstrates strong revenue visibility, ensuring sustainability and confidence in its future performance.

Anlon's global compliance is bolstered by Anvisa approval and 21 DMF filings, supporting strategic market penetrations, particularly in regulated markets.